From Myricetin to the Discovery of Novel Natural Human ENPP1 Inhibitors: A Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and MM/GBSA Study

It was recently revealed that naturally occurring myricetin can inhibit ectonucleotidase ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), which, in turn, can treat ischemic cardiac injury. However, due to myricetin’s poor druggability, its further developments are relatively limited, whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Shaohan, Shao, Zhiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573336/
https://www.ncbi.nlm.nih.gov/pubmed/36234712
http://dx.doi.org/10.3390/molecules27196175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573336/
https://www.ncbi.nlm.nih.gov/pubmed/36234712
http://dx.doi.org/10.3390/molecules27196175

Ejemplares similares